- Home
- VSTM vs PNNT Comparison
VSTM vs PNNT Comparison
Compare VSTM & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- PNNT
- Stock Information
- Founded
- VSTM 2010
- PNNT 2007
- Country
- VSTM United States
- PNNT United States
- Employees
- VSTM N/A
- PNNT N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- PNNT Finance: Consumer Services
- Sector
- VSTM Health Care
- PNNT Finance
- Exchange
- VSTM Nasdaq
- PNNT Nasdaq
- Market Cap
- VSTM 425.9M
- PNNT 442.7M
- IPO Year
- VSTM 2012
- PNNT 2007
- Fundamental
- Price
- VSTM $6.14
- PNNT $7.44
- Analyst Decision
- VSTM Strong Buy
- PNNT Sell
- Analyst Count
- VSTM 9
- PNNT 3
- Target Price
- VSTM $12.63
- PNNT $5.88
- AVG Volume (30 Days)
- VSTM 2.5M
- PNNT 404.6K
- Earning Date
- VSTM 08-07-2025
- PNNT 08-11-2025
- Dividend Yield
- VSTM N/A
- PNNT 12.90%
- EPS Growth
- VSTM N/A
- PNNT N/A
- EPS
- VSTM N/A
- PNNT 0.73
- Revenue
- VSTM $10,000,000.00
- PNNT $138,371,000.00
- Revenue This Year
- VSTM $81.24
- PNNT N/A
- Revenue Next Year
- VSTM $408.06
- PNNT N/A
- P/E Ratio
- VSTM N/A
- PNNT $10.19
- Revenue Growth
- VSTM N/A
- PNNT N/A
- 52 Week Low
- VSTM $2.10
- PNNT $5.72
- 52 Week High
- VSTM $9.10
- PNNT $7.45
- Technical
- Relative Strength Index (RSI)
- VSTM 66.83
- PNNT 73.09
- Support Level
- VSTM $4.86
- PNNT $7.23
- Resistance Level
- VSTM $5.62
- PNNT $7.45
- Average True Range (ATR)
- VSTM 0.38
- PNNT 0.10
- MACD
- VSTM 0.18
- PNNT 0.02
- Stochastic Oscillator
- VSTM 91.23
- PNNT 97.12
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.